Keisha Lowther, MD
Pediatrics · Tuscaloosa, ALNPI 1134336886
Payments from drug & device makers
Across 35 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$87
- GSK$76
- Novo Nordisk$61
- Merck$49
- Sanofi-aventis U.S. LLC$37
- Viiv Healthcare Company$33
- plus $323 from 14 others
What the payments were for
- Food & beverage$666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $87 |
| GSK | 3 | $76 |
| Novo Nordisk | 3 | $61 |
| Merck | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Viiv Healthcare Company | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Exact Sciences | 2 | $32 |
| Dexcom, Inc. | 2 | $32 |
| Seqirus USA Inc | 1 | $28 |
| AbbVie | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Qiagen, LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Pfizer | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$666 in reported general payments places this provider in the 65th percentile of 908 pediatrics providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 169 | $1,988 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,154 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 71 | $914 |
| Tramadol Hcl | 87 | $499 |
| Atorvastatin Calcium | 32 | $329 |
| Levothyroxine Sodium | 37 | $324 |
| Omeprazole | 18 | $222 |
| Losartan Potassium | 18 | $172 |
| Amlodipine Besylate | 38 | $170 |
| Pregabalin | 16 | $156 |
| Lovastatin | 13 | $137 |
| Simvastatin | 18 | $129 |
| Glipizide | 13 | $117 |
| Fluticasone Propionate | 17 | $116 |
| Metformin Hcl | 20 | $114 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Tuscaloosa
- Suresh BoppanaBirmingham$2.5M
- William JohnstonBirmingham$2M
- Max HaleBirmingham$1.3M
- Bhagwan BangOpp$427K
- Ibrahim AhmedMobile$193K
- David GallowayBirmingham$174K
- Tamera Coyne-BeasleyBirmingham$154K
- Terry WallBirmingham$147K
- Linda HammettBirmingham$123K
- Darby McElderryBirmingham$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.